4.6 Review

Chaperoning G Protein-Coupled Receptors: From Cell Biology to Therapeutics

期刊

ENDOCRINE REVIEWS
卷 35, 期 4, 页码 602-647

出版社

ENDOCRINE SOC
DOI: 10.1210/er.2013-1121

关键词

-

资金

  1. National Institutes of Health [OD012220, DK085040, DK099090, DK077213]
  2. American Diabetes Association [1-12-BS212]
  3. Diabetes Action Research and Education Foundation
  4. Auburn University Intramural Grant Program
  5. Interdisciplinary Grant Program of the College of Veterinary Medicine at Auburn University

向作者/读者索取更多资源

G protein-coupled receptors (GPCRs) are membrane proteins that traverse the plasma membrane seven times (hence, are also called 7TM receptors). The polytopic structure of GPCRs makes the folding of GPCRs difficult and complex. Indeed, many wild-type GPCRs are not folded optimally, and defects in folding are the most common cause of genetic diseases due to GPCR mutations. Both general and receptor-specific molecular chaperones aid the folding of GPCRs. Chemical chaperones have been shown to be able to correct the misfolding in mutant GPCRs, proving to be important tools for studying the structure-function relationship of GPCRs. However, their potential therapeutic value is very limited. Pharmacological chaperones (pharmacoperones) are potentially important novel therapeutics for treating genetic diseases caused by mutations in GPCR genes that resulted in misfolded mutant proteins. Pharmacoperones also increase cell surface expression of wild-type GPCRs; therefore, they could be used to treat diseases that do not harbor mutations in GPCRs. Recent studies have shown that indeed pharmacoperones work in both experimental animals and patients. High-throughput assays have been developed to identify new pharmacoperones that could be used as therapeutics for a number of endocrine and other genetic diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据